Research records indexed for Cerebrolysin
This page carries 12 of the 664 records that the literature query returned for Cerebrolysin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 652 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Cerebrolysin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin pmid:37052231 | 2023 | Research Support, Non-U.S. Gov't, Review | other | Not stated | Indexed as research support, non-u.s. gov't, review. study model from MeSH "Humans" with no interventional publication type. subject headings: Dementia; Vascular Endothelial Growth Factor A; Amino Acids; Neuroprotective Agents; Stroke. |
| Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use pmid:32808294 | 2021 | Review | other | Not stated | Indexed as review. study model from MeSH "Humans" with no interventional publication type. subject headings: Alzheimer Disease; Amino Acids; Biomarkers; Cognitive Dysfunction. |
| Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes pmid:33515100 | 2021 | Review | other | Not stated | Indexed as review. study model from MeSH "Humans" with no interventional publication type. subject headings: Amino Acids; Neuroprotective Agents; Stroke; Brain Injuries, Traumatic. |
| Anti-depressant effect of cerebrolysin in reserpine-induced depression in rats: Behavioral, biochemical, molecular and immunohistochemical evidence pmid:33279466 | 2021 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Hippocampus; Cerebral Cortex; Rats, Wistar; Disease Models, Animal; Inflammation. |
| Therapeutic effect of Cerebrolysin on reducing impaired cerebral endothelial cell permeability pmid:33661804 | 2021 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Blood-Brain Barrier; Cell Line; Endothelial Cells; Amino Acids; Neuroprotective Agents. |
| Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial pmid:31897941 | 2020 | Randomized Controlled Trial | human trial | Not stated | Indexed as randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Amino Acids; Neuroprotective Agents; Severity Of Illness Index; Glasgow Coma Scale; Prospective Studies. |
| Cerebrolysin prevents sleep deprivation induced memory impairment and oxidative stress pmid:31987894 | 2020 | Research Support, Non-U.S. Gov't | rodent | Not stated | Indexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Hippocampus; Rats, Wistar; Memory Disorders; Sleep Deprivation; Amino Acids. |
| Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial pmid:31494820 | 2020 | Clinical Trial, Phase III, Multicenter Study | human trial | Not stated | Indexed as clinical trial, phase iii, multicenter study. study model from MeSH "Humans" with publication type "clinical trial, phase iii". subject headings: Acute Disease; Amino Acids; Neuroprotective Agents; Severity Of Illness Index; Asia, Southeastern. |
| Cerebrolysin for vascular dementia pmid:31710397 | 2019 | Meta-Analysis, Research Support, Non-U.S. Gov't | other | Not stated | Indexed as meta-analysis, research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Dementia, Vascular; Amino Acids; Nootropic Agents; Cognition; Cost Of Illness. |
| Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials pmid:29248999 | 2018 | Meta-Analysis, research-article | other | Not stated | Indexed as meta-analysis, research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Brain Ischemia; Amino Acids; Neuroprotective Agents; Randomized Controlled Trials As Topic; Stroke. |
| Cerebrolysin: a multi-target drug for recovery after stroke pmid:30004268 | 2018 | Review | other | Not stated | Indexed as review. study model from MeSH "Humans" with no interventional publication type. subject headings: Brain Ischemia; Amino Acids; Neuroprotective Agents; Severity Of Illness Index; Recovery Of Function. |
| Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial prefrontal cortex ischemia pmid:30054019 | 2018 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Mice, Inbred Balb C". subject headings: Prefrontal Cortex; Neurons; Mice, Inbred BALB C; Brain Ischemia; Disease Models, Animal. |
Where this page sits
Compound page: Cerebrolysin. Class: Neuroactive peptides.
Retrieved 2026-10-10.
Sources
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:cerebrolysin
- Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals. CNS & neurological disorders drug targets (2012). pmid:22229324
- The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs of today (Barcelona, Spain : 1998) (2012). pmid:22514792
- Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke (2016). pmid:26564102
- Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke (2012). pmid:22282884
- Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2018). pmid:29248999
- Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. Journal of neuroscience research (2010). pmid:20857512
- Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke (2013). pmid:23696546
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.